Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Drug-induced systemic lupus erythematosus

Progress in Clinical Immunology

|January 1, 1980

Summary

This summary is machine-generated.

Drug-induced systemic lupus erythematosus (SLE) is a reversible condition. While some drugs clearly cause SLE, the exact mechanisms and genetic factors influencing its development require further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multiscale design of cell-free biologically active architectural structures.

Frontiers in bioengineering and biotechnology·2023

Same author

Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC.

The European physical journal. C, Particles and fields·2022

Same author

Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.

The European physical journal. C, Particles and fields·2021

Same author

The combined effect of tranilast 8% liposomal gel on the final cosmesis of acne scarring in patients concomitantly treated by isotretinoin: prospective, double-blind, split-face study.

Clinical and experimental dermatology·2019

Same author

The effects of synthetic cannabinoids (SCs) on brain structure and function.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2018

Same author

ANCA in lupus nephritis.

Lupus·2017

Same journal

Immune responses of human lymphocytes in vitro.

Progress in clinical immunology·1980

Same journal

Lymphocytotoxic antibodies.

Progress in clinical immunology·1980

Same journal

Prospects for the clinical control of IgE synthesis.

Progress in clinical immunology·1980

Same journal

Autoantibodies to the insulin receptor: clinical significance and experimental applications.

Progress in clinical immunology·1980

Same journal

Evaluation and clinical significance of circulating immune complexes.

Progress in clinical immunology·1980

Same journal

Defects of purine metabolism in immunodeficiency diseases.

Progress in clinical immunology·1977

See all related articles

Area of Science:

Immunology
Pharmacology
Rheumatology

Background:

Drug-induced systemic lupus erythematosus (SLE) is a recognized clinical entity.
Procainamide, hydralazine, and isoniazid are well-studied inducers of drug-related lupus.
Distinguishing drug-induced SLE from spontaneous SLE activation is crucial.

Purpose of the Study:

To clarify the nature of drug-induced SLE.
To explore potential mechanisms of drug-induced lupus.
To identify factors influencing the development of drug-induced SLE.

Main Methods:

Review of existing literature on drug-induced SLE.
Analysis of data from studies on procainamide, hydralazine, and isoniazid.
Consideration of in vitro and in vivo drug-antigen interactions.

Related Experiment Videos

Main Results:

Certain drugs reliably induce a reversible lupus syndrome.
Mechanisms of induction by procainamide, hydralazine, and isoniazid remain unclear.
Factors like cumulative dosage, acetylator phenotype, and drug biochemistry influence disease development.

Conclusions:

Drug-induced SLE is a distinct entity, though pathogenesis is not fully understood.
Genetic factors likely play a role in susceptibility to clinical symptoms.
Further research into drug-induced SLE may illuminate spontaneous SLE pathogenesis.